Bulletin
Investor Alert

Revolution Medicines Inc.

NAS: RVMD

GO
/marketstate/country/us

After Hours

/zigman2/quotes/216320743/composite

$

27.82

Change

+0.14 +0.51%

Volume

Volume 34,541

Sep 29, 2023, 6:09 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/216320743/composite

Previous close

$ 28.24

$ 27.68

Change

-0.56 -1.98%

Day low

Day high

$27.60

$28.57

Open
Open: 28.42

52 week low

52 week high

$17.47

$35.50

Open

Market cap

$3.08B

Average volume

1.21M

P/E ratio

N/A

Rev. per Employee

$120,016

EPS

-3.14

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/rvmd

MarketWatch News on RVMD

  1. Revolution Medicines upgraded to overweight from neutral at J.P. Morgan

    8:27 a.m. Feb. 28, 2023

    - Tomi Kilgore

  2. Revolution Medicines started at outperform with $30 stock price target at Oppenheimer

    7:28 a.m. Oct. 21, 2022

    - Tomi Kilgore

  3. Revolution Medicines started at neutral with $24 stock price target at BofA Securities

    10:24 a.m. May 20, 2022

    - Tomi Kilgore

  4. Revolution Medicines started at hold with $34 stock price target at Stifel Nicolaus

    7:43 a.m. Sept. 23, 2021

    - Tomi Kilgore

  5. Cancer Meeting Could Ignite These Biotech Stocks

    6:00 a.m. Oct. 24, 2020

    - Barron's Online

  6. The Pandemic Speeds Up the Health-Care Revolution

    6:01 p.m. Oct. 6, 2020

    - Barron's Online

  7. Cancer Meeting’s High Hopes for Amgen and Gilead

    8:22 a.m. Sept. 21, 2020

    - Barron's Online

  8. Why Blackstone Stock Looks Attractive

    10:29 p.m. May 22, 2020

    - Barron's Online

  9. Revolution Medicines shares soar 85% in trading debut

    12:16 p.m. Feb. 13, 2020

    - Ciara Linnane

  10. Revolution Medicines prices IPO at $17 a share

    8:56 p.m. Feb. 12, 2020

    - Jeremy C. Owens

  11. Revolution Medicines increases size of planned IPO and raises price range

    8:07 a.m. Feb. 11, 2020

    - Ciara Linnane

  12. Revolution Medicines to offer 14 mln shares in planned IPO, priced at $16 to $17 each

    8:07 a.m. Feb. 11, 2020

    - Ciara Linnane

/news/nonmarketwatch/company/us/rvmd

Other News on RVMD

/news/pressrelease/company/us/rvmd

Press Releases on RVMD

Rates »

Link to MarketWatch's Slice.